Does NEFOPAM Cause Interstitial lung disease? 21 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Interstitial lung disease have been filed in association with NEFOPAM. This represents 0.7% of all adverse event reports for NEFOPAM.
21
Reports of Interstitial lung disease with NEFOPAM
0.7%
of all NEFOPAM reports
3
Deaths
19
Hospitalizations
How Dangerous Is Interstitial lung disease From NEFOPAM?
Of the 21 reports, 3 (14.3%) resulted in death, 19 (90.5%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEFOPAM. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does NEFOPAM Cause?
Cholestasis (135)
Confusional state (134)
Acute kidney injury (130)
Hepatocellular injury (107)
Hepatic cytolysis (101)
Eosinophilia (97)
Rash maculo-papular (97)
Drug reaction with eosinophilia and systemic symptoms (90)
Coma (86)
Somnolence (84)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which NEFOPAM Alternatives Have Lower Interstitial lung disease Risk?
NEFOPAM vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG
NEFOPAM vs NELARABINE
NEFOPAM vs NELFINAVIR
NEFOPAM vs NELVUTAMIG
NEFOPAM vs NEMOLIZUMAB